BBT
BBT is an enhancer of impaired glucose-stimulated insulin secretion (GSIS). BBT exhibits anti-hyperglycemia activity, and protects β-cells from cytokine- or streptozotocin (STZ ) -induced cell death in type 2 diabetes models. BBT acts function via cAMP/PKA and long-lasting (L-type) voltage-dependent Ca2+ channel/CaMK2 pathway[1].
Product Specifications
CAS Number
445000-45-3
UNSPSC
12352005
Target
Calcium Channel
Type
Reference compound
Related Pathways
Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/bbt.html
Purity
99.71
Solubility
DMSO : 125 mg/mL (ultrasonic)
Smiles
C1(=CC=C(Br)S1)C(=O)NC1=CC=CC=C1C(C1C=CC=CC=1)=O
Molecular Formula
C18H12BrNO2S
Molecular Weight
386.27
References & Citations
[1]Yao XG, et al. BBT improves glucose homeostasis by ameliorating -cell dysfunction in type 2 diabetic mice. J Endocrinol. 2015 Mar;224 (3) :327-41.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Dedicated for Diverse Library
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
RNF121 (RING Finger Protein 121, FLJ11099) (APC)
RNF121 (RING Finger Protein 121, FLJ11099) (APC)